Terminal Sterilization Services Market Size, Share & Trends Analysis Report By Product (Equipment, Consumables, Service & Maintenance, Connectivity Solutions & Software), By Method (Low Temperature), By End-use, By Region, And Segment Forecasts, 2025 - 20

Publisher Grand View Research

Published Sep 12, 2025

Length 120 Pages

SKU # GV20471035

Description

Terminal Sterilization Services Market Summary

The global terminal sterilization services market size was estimated at USD 13.09 billion in 2024 and is projected to reach USD 25.54 billion by 2033, growing at a CAGR of 7.76% from 2025 to 2033. The increasing prevalence of healthcare-associated infections and the rising number of surgical procedures are the primary driving factors contributing to the industry growth.

The increasing prevalence of healthcare-associated infections (HAIs) is projected to contribute significantly to the growth of the terminal sterilization services industry. Hospitals & Clinics are under continuous pressure to improve sterilization standards to prevent infections caused by inadequately sterilized equipment. For instance, according to data released by the European Centre for Disease Prevention and Control, a European Union Agency, in May 2024, approximately 4.3 million hospitalized patients across the EU and European Economic Area (EEA) are affected by HAIs annually. These infections pose serious health risks and place a significant strain on healthcare systems.

This reflects a serious public health concern and highlights the financial and operational burden placed on hospitals and healthcare systems. As a result, healthcare providers and regulatory authorities are placing increased emphasis on terminal sterilization services processes to ensure product sterility and reduce infection risk.

Terminal sterilization, performed after packaging, ensures microbial inactivation, making it an essential step in infection prevention protocols. This escalating demand for effective infection controls due to growing healthcare-associated infections is anticipated to propel the market for terminal sterilization services significantly.

Another major factor driving the industry growth is the growing surgical procedures in hospitals. For instance, according to a Eurostat report, the two most common surgical operations and procedures performed in EU hospitals are cataract surgery and caesarean sections.

Global Terminal Sterilization Services Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global terminal sterilization services market report on the basis of product, method, end-use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)
Equipment
Consumables
Service & Maintenance
Connectivity Solutions and Software
Method Outlook (Revenue, USD Million, 2021 - 2033)
Low Temperature
Hydrogen Peroxide (H2O2)
Ethylene Oxide (EtO)
Others
High Temperature (Steam Sterilization)
Systems
Consumables
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals & Clinic
Pharma and Nutraceuticals
Ambulatory Surgical Centres (ASCs)
Medical Device Manufacturers/Packaging
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
Kuwait
UAE

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation & Scope; 1.2. Segment Definitions; 1.2.1. Product; 1.2.2. Method; 1.2.3. End Use; 1.2.4. Regional scope; 1.2.5. Estimates and forecasts timeline; 1.3. Research Methodology; 1.4. Information Procurement; 1.4.1. Purchased database; 1.4.2. GVR’s internal database; 1.4.3. Secondary sources; 1.4.4. Primary research; 1.4.5. Details of primary research; 1.4.5.1. Data for primary interviews in North America; 1.4.5.2. Data for primary interviews in Europe; 1.4.5.3. Data for primary interviews in Asia Pacific; 1.4.5.4. Data for primary interviews in Latin America; 1.4.5.5. Data for Primary interviews in MEA; 1.5. Information or Data Analysis; 1.5.1. Data analysis models; 1.6. Market Formulation & Validation; 1.7. Model Details; 1.7.1. Commodity flow analysis (Model 1); 1.7.2. Approach 1: Commodity flow approach; 1.7.3. Volume price analysis (Model 2); 1.7.4. Approach 2: Volume price analysis; 1.8. List of Secondary Sources; 1.9. List of Primary Sources; 1.10. Objectives
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.3. Competitive Insights
Chapter 3. Terminal Sterilization Services Market Variables, Trends, & Scope: 3.1. Market Lineage Outlook; 3.1.1. Ancillary Market Outlook; 3.2. Market Dynamics; 3.2.1. Market Driver Analysis; 3.2.1.1. Increasing prevalence of healthcare-associated infections (HAIs); 3.2.1.2. Rising number of Surgical Procedures; 3.2.1.3. Stringent Regulatory and Compliance Requirement; 3.2.2. Market Restraint Analysis; 3.2.2.1. Evolving EtO Sterilization and concerns associated with EtO; 3.2.3. Market Opportunities Analysis; 3.2.3.1. Growing Pharmaceutical and Medical Device Industry; 3.2.3.2. Acquisition and Expansion of Terminal Sterilization Services; 3.2.3.3. Technological innovations; 3.2.4. Market Challenges Analysis; 3.2.4.1. Labor Shortage Sterile Processing Department; 3.2.4.2. Regulatory complexity; 3.3. Terminal Sterilization Services Market Analysis Tools; 3.3.1. Industry Analysis - Porter’s; 3.3.1.1. Bargaining power of suppliers; 3.3.1.2. Bargaining power of buyers; 3.3.1.3. Threat of substitutes; 3.3.1.4. Threat of new entrants; 3.3.1.5. Competitive rivalry; 3.3.2. PESTEL Analysis; 3.3.2.1. Political & Legal Landscape; 3.3.2.2. Economic and Social Landscape; 3.3.2.3. Technological landscape
Chapter 4. Terminal Sterilization Services Market: Product Estimates & Trend Analysis: 4.1. Segment Dashboard; 4.2. Terminal Sterilization Services Market: Product Movement Analysis & Market Share, 2024 & 2030; 4.3. Equipment; 4.3.1. Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 4.4. Consumables; 4.4.1. Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 4.5. Service & Maintenance; 4.5.1. Service & Maintenance Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 4.6. Connectivity Solutions and Software; 4.6.1. Connectivity Solutions and Software Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Terminal Sterilization Services Market: Method Estimates & Trend Analysis: 5.1. Segment Dashboard; 5.2. Terminal Sterilization Services Market: Method Movement Analysis & Market Share, 2024 & 2030; 5.3. Low Temperature; 5.3.1. Low Temperature Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.3.1.1. Hydrogen Peroxide (H2O2); 5.3.1.1.1. Hydrogen Peroxide (H2O2) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.3.1.2. Ethylene Oxide (EtO); 5.3.1.2.1. Ethylene Oxide (EtO) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.3.1.3. Others; 5.3.1.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.4. High Temperature (Steam Sterilization); 5.4.1. High Temperature (Steam Sterilization) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.4.1.1. Systems; 5.4.1.1.1. Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.4.1.2. Consumables; 5.4.1.2.1. Consumables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Terminal Sterilization Services Market: End Use Estimates & Trend Analysis: 6.1. Segment Dashboard; 6.2. Terminal Sterilization Services Market: End Use Movement Analysis & Market Share, 2024 & 2030; 6.3. Hospitals & Clinic; 6.3.1. Hospitals & Clinic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 6.4. Pharma and Nutraceuticals; 6.4.1. Pharma and Nutraceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 6.5. Ambulatory Surgical Centers (ASCs); 6.5.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 6.6. Medical Device Manufacturers/Packaging; 6.6.1. Medical Device Manufacturers/Packaging Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 6.7. Others; 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Terminal Sterilization Services Market: Regional Estimates & Trend Analysis: 7.1. Regional Outlook; 7.2. Terminal Sterilization Services Market: Regional Movement Analysis & Market Share, 2024 & 2030; 7.3. North America; 7.3.1. North America Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.3.2. U.S.; 7.3.2.1. Key Country Dynamics; 7.3.2.2. Competitive Scenario; 7.3.2.3. Regulatory Scenario; 7.3.2.4. Reimbursement Scenario; 7.3.2.5. U.S. Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.3.3. Canada; 7.3.3.1. Key Country Dynamics; 7.3.3.2. Competitive Scenario; 7.3.3.3. Regulatory Scenario; 7.3.3.4. Reimbursement Scenario; 7.3.3.5. Canada Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.3.4. Mexico; 7.3.4.1. Key Country Dynamics; 7.3.4.2. Competitive Scenario; 7.3.4.3. Regulatory Scenario; 7.3.4.4. Reimbursement Scenario; 7.3.4.5. Mexico Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.4. Europe; 7.4.1. Europe Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.4.2. UK; 7.4.2.1. Key Country Dynamics; 7.4.2.2. Competitive Scenario; 7.4.2.3. Regulatory Scenario; 7.4.2.4. Reimbursement Scenario; 7.4.2.5. UK Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.4.3. Germany; 7.4.3.1. Key Country Dynamics; 7.4.3.2. Competitive Scenario; 7.4.3.3. Regulatory Scenario; 7.4.3.4. Reimbursement Scenario; 7.4.3.5. Germany Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.4.4. France; 7.4.4.1. Key Country Dynamics; 7.4.4.2. Competitive Scenario; 7.4.4.3. Regulatory Scenario; 7.4.4.4. Reimbursement Scenario; 7.4.4.5. France Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.4.5. Italy; 7.4.5.1. Key Country Dynamics; 7.4.5.2. Competitive Scenario; 7.4.5.3. Regulatory Scenario; 7.4.5.4. Reimbursement Scenario; 7.4.5.5. Italy Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.4.6. Spain; 7.4.6.1. Key Country Dynamics; 7.4.6.2. Competitive Scenario; 7.4.6.3. Regulatory Scenario; 7.4.6.4. Reimbursement Scenario; 7.4.6.5. Spain Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.4.7. Denmark; 7.4.7.1. Key Country Dynamics; 7.4.7.2. Competitive Scenario; 7.4.7.3. Regulatory Scenario; 7.4.7.4. Reimbursement Scenario; 7.4.7.5. Denmark Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.4.8. Sweden; 7.4.8.1. Key Country Dynamics; 7.4.8.2. Competitive Scenario; 7.4.8.3. Regulatory Scenario; 7.4.8.4. Reimbursement Scenario; 7.4.8.5. Sweden Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.4.9. Norway; 7.4.9.1. Key Country Dynamics; 7.4.9.2. Competitive Scenario; 7.4.9.3. Regulatory Scenario; 7.4.9.4. Reimbursement Scenario; 7.4.9.5. Norway Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5. Asia Pacific; 7.5.1. Asia Pacific Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5.2. Japan; 7.5.2.1. Key Country Dynamics; 7.5.2.2. Competitive Scenario; 7.5.2.3. Regulatory Scenario; 7.5.2.4. Reimbursement Scenario; 7.5.2.5. Japan Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5.3. China; 7.5.3.1. Key Country Dynamics; 7.5.3.2. Competitive Scenario; 7.5.3.3. Regulatory Scenario; 7.5.3.4. Reimbursement Scenario; 7.5.3.5. China Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5.4. India; 7.5.4.1. Key Country Dynamics; 7.5.4.2. Competitive Scenario; 7.5.4.3. Regulatory Scenario; 7.5.4.4. Reimbursement Scenario; 7.5.4.5. India Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5.5. South Korea; 7.5.5.1. Key Country Dynamics; 7.5.5.2. Competitive Scenario; 7.5.5.3. Regulatory Scenario; 7.5.5.4. Reimbursement Scenario; 7.5.5.5. South Korea Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5.6. Australia; 7.5.6.1. Key Country Dynamics; 7.5.6.2. Competitive Scenario; 7.5.6.3. Regulatory Scenario; 7.5.6.4. Reimbursement Scenario; 7.5.6.5. Australia Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5.7. Thailand; 7.5.7.1. Key Country Dynamics; 7.5.7.2. Competitive Scenario; 7.5.7.3. Regulatory Scenario; 7.5.7.4. Reimbursement Scenario; 7.5.7.5. Thailand Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6. Latin America; 7.6.1. Latin America Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.2. Brazil; 7.6.2.1. Key Country Dynamics; 7.6.2.2. Competitive Scenario; 7.6.2.3. Regulatory Scenario; 7.6.2.4. Reimbursement Scenario; 7.6.2.5. Brazil Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.3. Argentina; 7.6.3.1. Key Country Dynamics; 7.6.3.2. Competitive Scenario; 7.6.3.3. Regulatory Scenario; 7.6.3.4. Reimbursement Scenario; 7.6.3.5. Argentina Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7. Middle East & Africa; 7.7.1. Middle East & Africa Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.2. South Africa; 7.7.2.1. Key Country Dynamics; 7.7.2.2. Competitive Scenario; 7.7.2.3. Regulatory Scenario; 7.7.2.4. Reimbursement Scenario; 7.7.2.5. South Africa Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.3. Saudi Arabia; 7.7.3.1. Key Country Dynamics; 7.7.3.2. Competitive Scenario; 7.7.3.3. Regulatory Scenario; 7.7.3.4. Reimbursement Scenario; 7.7.3.5. Saudi Arabia Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.4. UAE; 7.7.4.1. Key Country Dynamics; 7.7.4.2. Competitive Scenario; 7.7.4.3. Regulatory Scenario; 7.7.4.4. Reimbursement Scenario; 7.7.4.5. UAE Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.5. Kuwait; 7.7.5.1. Key Country Dynamics; 7.7.5.2. Competitive Scenario; 7.7.5.3. Regulatory Scenario; 7.7.5.4. Reimbursement Scenario; 7.7.5.5. Kuwait Terminal Sterilization Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape: 8.1. Market Participant Categorization; 8.2. Key Company Profiles; 8.2.1. ASP (Fortive); 8.2.1.1. Company Overview; 8.2.1.2. Financial Performance; 8.2.1.3. Product Benchmarking; 8.2.1.4. Strategic Initiatives; 8.2.2. Bionics Scientific (a Unit of Kartal Projects Pvt Ltd.); 8.2.2.1. Company Overview; 8.2.2.2. Financial Performance; 8.2.2.3. Product Benchmarking; 8.2.2.4. Strategic Initiatives; 8.2.3. DE LAMA S.P.A.; 8.2.3.1. Company Overview; 8.2.3.2. Financial Performance; 8.2.3.3. Product Benchmarking; 8.2.3.4. Strategic Initiatives; 8.2.4. Genist Technocracy Pvt. Ltd.; 8.2.4.1. Company Overview; 8.2.4.2. Financial Performance; 8.2.4.3. Product Benchmarking; 8.2.4.4. Strategic Initiatives; 8.2.5. Getinge; 8.2.5.1. Company Overview; 8.2.5.2. Financial Performance; 8.2.5.3. Product Benchmarking; 8.2.5.4. Strategic Initiatives; 8.2.6. Andersen Sterilizers; 8.2.6.1. Company Overview; 8.2.6.2. Financial Performance; 8.2.6.3. Product Benchmarking; 8.2.6.4. Strategic Initiatives; 8.2.7. Labotronics Scientific; 8.2.7.1. Company Overview; 8.2.7.2. Financial Performance; 8.2.7.3. Product Benchmarking; 8.2.7.4. Strategic Initiatives; 8.2.8. Labtron Equipment Ltd; 8.2.8.1. Company Overview; 8.2.8.2. Financial Performance; 8.2.8.3. Product Benchmarking; 8.2.8.4. Strategic Initiatives; 8.2.9. STERIS; 8.2.9.1. Company Overview; 8.2.9.2. Financial Performance; 8.2.9.3. Product Benchmarking; 8.2.9.4. Strategic Initiatives; 8.2.10. Stryker; 8.2.10.1. Company Overview; 8.2.10.2. Financial Performance; 8.2.10.3. Product Benchmarking; 8.2.10.4. Strategic Initiatives; 8.2.11. Qingdao Antech Scientific Co., Ltd.; 8.2.11.1. Company Overview; 8.2.11.2. Financial Performance; 8.2.11.3. Product Benchmarking; 8.2.11.4. Strategic Initiatives; 8.2.12. MATACHANA; 8.2.12.1. Company Overview; 8.2.12.2. Financial Performance; 8.2.12.3. Product Benchmarking; 8.2.12.4. Strategic Initiatives; 8.2.13. Solventum; 8.2.13.1. Company Overview; 8.2.13.2. Financial Performance; 8.2.13.3. Product Benchmarking; 8.2.13.4. Strategic Initiatives; 8.2.14. Steelco S.p.A.; 8.2.14.1. Company Overview; 8.2.14.2. Financial Performance; 8.2.14.3. Product Benchmarking; 8.2.14.4. Strategic Initiatives; 8.2.15. RENOSEM CO., LTD.; 8.2.15.1. Company Overview; 8.2.15.2. Financial Performance; 8.2.15.3. Product Benchmarking; 8.2.15.4. Strategic Initiatives; 8.2.16. Tuttnauer; 8.2.16.1. Company Overview; 8.2.16.2. Financial Performance; 8.2.16.3. Product Benchmarking; 8.2.16.4. Strategic Initiatives; 8.2.17. Sterile Safequip and Chemicals LLP; 8.2.17.1. Company Overview; 8.2.17.2. Financial Performance; 8.2.17.3. Product Benchmarking; 8.2.17.4. Strategic Initiatives; 8.2.18. MMM Group; 8.2.18.1. Company Overview; 8.2.18.2. Financial Performance; 8.2.18.3. Product Benchmarking; 8.2.18.4. Strategic Initiatives; 8.2.19. SOLSTEO; 8.2.19.1. Company Overview; 8.2.19.2. Financial Performance; 8.2.19.3. Product Benchmarking; 8.2.19.4. Strategic Initiatives; 8.2.20. Sterigenics U.S., LLC - A Sotera Health company; 8.2.20.1. Company Overview; 8.2.20.2. Financial Performance; 8.2.20.3. Product Benchmarking; 8.2.20.4. Strategic Initiatives; 8.2.21. Canon Singapore Pte. Ltd.; 8.2.21.1. Company Overview; 8.2.21.2. Financial Performance; 8.2.21.3. Product Benchmarking; 8.2.21.4. Strategic Initiatives; 8.2.22. INSTECH SYSTEMS; 8.2.22.1. Company Overview; 8.2.22.2. Financial Performance; 8.2.22.3. Product Benchmarking; 8.2.22.4. Strategic Initiatives; 8.2.23. Shinva Medical Instrument Co., Ltd.; 8.2.23.1. Company Overview; 8.2.23.2. Financial Performance; 8.2.23.3. Product Benchmarking; 8.2.23.4. Strategic Initiatives; 8.2.24. Syntegon Technology GmbH; 8.2.24.1. Company Overview; 8.2.24.2. Financial Performance; 8.2.24.3. Product Benchmarking; 8.2.24.4. Strategic Initiatives; 8.2.25. Mudanjiang Plasma Physics Application Technology Co., Ltd (CASP); 8.2.25.1. Company Overview; 8.2.25.2. Financial Performance; 8.2.25.3. Product Benchmarking; 8.2.25.4. Strategic Initiatives; 8.2.26. Fedegari Autoclavi S.p.A.; 8.2.26.1. Company Overview; 8.2.26.2. Financial Performance; 8.2.26.3. Product Benchmarking; 8.2.26.4. Strategic Initiatives; 8.2.27. NovaSterilis; 8.2.27.1. Company Overview; 8.2.27.2. Financial Performance; 8.2.27.3. Product Benchmarking; 8.2.27.4. Strategic Initiatives; 8.3. Heat Map Analysis/ Company Market Position Analysis; 8.4. Company Market Share Analysis, 2024

Pricing

Currency Rates

Single User Email from Publisher $5,950
Multi User License Fulfilled by Publisher $6,950
Global Site License Email from Publisher $8,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now